Table 1.
B-mode US evaluation | Histopathological evaluation | |
---|---|---|
BI-RADS category | Benign n: 43; 54% | Malign n: 36; 46% |
5 | – | 30 (38%) |
4 | 28 (35%) | 6 (8%) |
3 | 15 (19%) | – |
B-mode US evaluation | Histopathological evaluation | |
---|---|---|
BI-RADS category | Benign n: 43; 54% | Malign n: 36; 46% |
5 | – | 30 (38%) |
4 | 28 (35%) | 6 (8%) |
3 | 15 (19%) | – |